0001668397-24-000055.txt : 20240308 0001668397-24-000055.hdr.sgml : 20240308 20240308170232 ACCESSION NUMBER: 0001668397-24-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Medpace Investors, LLC CENTRAL INDEX KEY: 0001524599 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37856 FILM NUMBER: 24735376 BUSINESS ADDRESS: STREET 1: 4620 WESLEY AVENUE CITY: CINCINNATI STATE: OH ZIP: 45212 BUSINESS PHONE: 513-579-9911 MAIL ADDRESS: STREET 1: 4620 WESLEY AVENUE CITY: CINCINNATI STATE: OH ZIP: 45212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medpace Holdings, Inc. CENTRAL INDEX KEY: 0001668397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 320434904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 BUSINESS PHONE: (513) 579-9911 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 4 1 wk-form4_1709935342.xml FORM 4 X0508 4 2024-03-06 0 0001668397 Medpace Holdings, Inc. MEDP 0001524599 Medpace Investors, LLC C/O MEDPACE HOLDINGS, INC. 5375 MEDPACE WAY CINCINNATI OH 45227 0 0 1 0 0 Common Stock 2024-03-06 4 S 0 100000 412.98 D 4833019 D Common Stock 2024-03-07 4 S 0 75000 410.74 D 4758019 D Common Stock 2024-03-08 4 S 0 25000 408.71 D 4733019 D The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. /s/ Stephen P. Ewald, Authorized Signatory for Medpace Investors, LLC 2024-03-08